Skip to main navigation Skip to search Skip to main content

Development, Involvement and Use of an Overarching In-House Registry for Clinical Trials

Torge Ablaß*, Friedrich Simon, Christina Schwitlick, Denise Olbrich, Kristina Brandt, Ina Hohensee, Nikolas Von Bubnoff, Claudia Baldus, Josef Ingenerf, Björn Schreiweis, Ann Kristin Kock-Schoppenhauer

*Corresponding author for this work

Abstract

Introduction Conducting clinical studies is an integral part of the clinical research repertoire of university hospitals. A wealth of organizational competences must always be available in a central location and in an up-to-date form for appropriate administration. Information such as the number of ongoing studies, and the number of enrolled participants is required for tasks related to e.g. sponsor quality management and KPIs. A registry for clinical trials can answer these questions and enhance the exchange of information. Methods Requirements for an in-house registry for clinical trials were defined in a multidisciplinary task force. The requirements included interfaces and key abilities to create customized reports to fulfill the obligation to provide evidence. Results The study registry is productive since May 2020 and internal interfaces have been implemented to ensure consistency between systems and the documented studies. Manually recorded data is enhanced by interfaces to primary registers. The comprehensive data set in the study register enables the creation of individual queries at any time for a variety of questions. Discussion The UKSH study register has already demonstrated its usefulness in various applications and several projects. The extensive data set and the modular realization allows many current and future requirements to be met.

Original languageEnglish
Title of host publicationVolume 317: German Medical Data Sciences 2024
Publication date30.08.2024
Publication statusPublished - 30.08.2024

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being
  2. SDG 9 - Industry, Innovation, and Infrastructure
    SDG 9 Industry, Innovation, and Infrastructure

Fingerprint

Dive into the research topics of 'Development, Involvement and Use of an Overarching In-House Registry for Clinical Trials'. Together they form a unique fingerprint.

Cite this